Cambridge Semantics Identified in Gartner’s ‘Hype Cycle for Life Sciences 2014’ Report

Share Article

Anzo Software Suite Has Demonstrated Proven Benefits in Life Sciences and Pharmaceutical Industries

News Image
“We believe the Gartner report validates our efforts to help life sciences customers achieve fast ROI,” said Alok Prasad, president of Cambridge Semantics.

Cambridge Semantics, the leading provider of Smart Data solutions driven by Semantic Web technology, was named in the recent ‘Hype Cycle for Life Sciences 2014 ’ report by Gartner, Inc.

The report details key insights pertaining to the benefits in the knowledge graphing category.

According to Gartner analysts Michael Shanler and Stephen Davies, “The use of these systems can help accelerate innovation activities, expose complex relationships with scientific stakeholders, and support collaboration and innovation strategies as they relate to drug discovery, translational medicine, competitive intelligence, and clinical research.”

Semantic knowledge graphing includes software and services that enable researchers to search, mine, aggregate and share complex data relationships. The systems map internal and external data sets, have the capability to continually search for updated information, and support synchronous sharing.

“We believe the Gartner report validates our efforts to help life sciences customers achieve fast ROI,” said Alok Prasad, president of Cambridge Semantics. “With the volume of data exploding in the field, we see software suites like Anzo allowing pharmaceutical researchers and others to easily link, analyze and manage the growing amounts of diverse data”

Currently, pharmaceutical companies are using Cambridge Semantics’ Anzo Pharma Information workbench to rapidly build customized solutions for competitive intelligence, drug safety and pharmacovigilance, clinical data collection and reuse, R&D knowledge management, clinical trial metadata management and commercial compliance. Given adoption of semantic standards by regulatory bodies like the FDA and by various industry groups, the number of use cases continues to rapidly expand.

About Cambridge Semantics
Cambridge Semantics provides the award-winning Anzo software suite, an open platform for building interactive Smart Data solutions. Enterprises face an increasing need to rapidly discover, understand, combine, analyze, and manage data from diverse sources both from within and across organizational boundaries. Anzo uses common, conceptual business models to make it easy for both IT and end users to deal with these needs by rapidly creating solutions to address specific analytics and data management business problems.

Cambridge Semantics is privately held and based in Boston, Massachusetts. For more information visit http://www.cambridgesemantics.com or follow us on Facebook, LinkedIn and Twitter: @CamSemantics.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Gartner, Inc., Hype Cycle for Life Sciences 2014, Michael Shanler and Stephen Davies, July 2014

Share article on social media or email:

View article via:

Pdf Print

Contact Author